Search

everythinglearnresearchcommunity

for

Search:↓

Piezoelectric Nanogenerators are promising for non-invasive health monitoring but need efficiency and durability improvements.

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

A patient with Myotonic dystrophy type 1 had multiple tongue hemangiomas and was sensitive to anesthesia.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

A protein called MPZL3 in mitochondria slows down hair growth and could be a target for treating hair growth disorders.

Hair keratin treatments can be harmful, potentially causing health issues like skin reactions and cancer.

Myoepithelial cells can repair airways after severe injury.

Children under 18 had milder SARS with no deaths, but teenagers faced higher severe illness risk, and effective treatments were uncertain.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

Tofacitinib is an effective and safe treatment for alopecia areata.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

A child on life support experienced rapid hair loss due to severe illness affecting hair growth.

Long COVID causes lasting symptoms and needs ongoing care.

COVID-19 can cause various skin issues, helping doctors diagnose it early.

After severe COVID-19, lung damage can improve, detected effectively by lung-ultrasound, and high pressure support during hospitalization can increase lung artery size. Also, about 22% of patients had lung blood clots, and when treated, they recovered faster.

Hair loss can happen after severe H1N1 flu but usually grows back in 4 months.

Opioid painkillers can cause many side effects, including breathing problems and addiction, but are generally considered safe when used properly.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.